Tender detail

Pazopanib medicine discount agreements under an open-house model

Summary

The procurement concerns non-exclusive discount agreements for medicines containing the active ingredient pazopanib (ATC code L01EX03), concluded through an open-house model. The purchase volume is unknown and no minimum quantities are guaranteed; agreements end no later than 31 January 2029.

Reference number
fb16105b-1e1c-4c96-bc2d-5f8b418d66fe
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2029-01-31
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.